tm logo
GEMPSIIVO
Live/Pending
PUBLISHED FOR OPPOSITION

on 12 Nov 2024

Last Applicant/ Owned by

9804 Medical Center Drive

Rockville

MD

20850

Serial Number

98196371 filed on 25th Sep 2023

Registration Number

N/A

Correspondent Address

William R. Samuels

William R. Samuels COLE-FRIEMAN & MALLON LLP

NEW YORK, NY 10022

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

GEMPSIIVO

Biological preparations for medical use in the treatment of genetic diseases and disorders, and central nervous system (CNS) disorders, namely, neurodegenerative disorders; pharmaceutical preparations, namely, recombinant adeno-associated viral (rAAV) vectors for use in gene therapy; Pharmaceutical preparations for the treatment of genetic diseases and disorders and central nervous system (CNS) di Read More

Classification Information


Class [005]
Pharmaceutical Products


Biological preparations for medical use in the treatment of genetic diseases and disorders, and central nervous system (CNS) disorders, namely, neurodegenerative disorders; pharmaceutical preparations, namely, recombinant adeno-associated viral (rAAV) vectors for use in gene therapy; Pharmaceutical preparations for the treatment of genetic diseases and disorders and central nervous system (CNS) disorders, namely, neurodegenerative disorders; Pharmaceutical preparations for use in gene therapy; Clinical medical reagents for use in gene therapy; Pharmaceutical preparations for the treatment of genetic disorders and neurodegenerative disorders; Therapeutic pharmaceutical compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; Pharmaceutical preparations containing adeno-associated viral (AAV) vectors and nucleic acids for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders, namely, lysosomal storage disorders; gene therapy preparation for medical use containing genetic materials for sustained protein expression, namely, lysosomal enzyme expression


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98196371

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 1959.26

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Nov 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12th Nov 2024PUBLISHED FOR OPPOSITION
23rd Oct 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03rd Oct 2024APPROVED FOR PUB - PRINCIPAL REGISTER
03rd Oct 2024EXAMINERS AMENDMENT -WRITTEN
03rd Oct 2024EXAMINER'S AMENDMENT ENTERED
03rd Oct 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03rd Oct 2024EXAMINERS AMENDMENT E-MAILED
24th Jul 2024TEAS VOLUNTARY AMENDMENT RECEIVED
24th Jul 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED